Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept.

Choukroun J, Ghanaati S. · 2018

Read Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept. by Choukroun J, Ghanaati S. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5808086.txt.

Introduction

Choukroun and Ghanaati test gentler spinning for platelet-rich fibrin. Doctors spin a patient's blood to make a healing concentrate. The fluid holds platelets, white cells, and growth factors. Standard spins may throw away much of that value.

Blood from six healthy donors was spun at forces from 710 down to 44 g. Lower force left far more platelets and white cells in the fluid. Growth factors VEGF and TGF-beta1 also rose. The lowest setting gave the richest mix. The authors name this the low speed concept. Readers get a simple tweak that could boost wound care.

Catalog record

CREATORChoukroun J, Ghanaati S.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5808086

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept By J. Choukroun, S. Ghanaati Published in: European Journal of Trauma and Emergency Surgery DOI: 10.1007/s00068-017-0767-9 ABSTRACT Purpose The aim of this study was to analyze systematically the influence of the relative centrifugation force (RCF) on leukocytes, platelets and growth factor release within fluid platelet-rich fibrin matrices (PRF). Materials and methods Systematically using peripheral blood from six healthy volunteers, the RCF was reduced four times for each of the three experimental protocols (I–III) within the spectrum (710–44 g), while maintaining a constant centrifugation time. Flow cytometry was applied to determine the platelets and leukocyte number. The growth factor concentration was quantified 1 and 24 h after clotting using ELISA. Results Reducing RCF in accordance with protocol-II (177 g) led to a significantly higher platelets and leukocytes numbers compared to protocol-I (710 g). Protocol-III (44 g) showed a highly significant increase of leukocytes and platelets number in comparison to -I and -II. The growth factors’ concentration of VEGF and TGF-β1 was significantly higher in protocol-II compared to -I, whereas protocol-III exhibited significantly higher growth factor concentration compared to protocols-I and -II. These findings were observed among 1 and 24 h after clotting, as well as the accumulated growth factor concentration over 24 h. Discussion Based on the results, it has been demonstrated that it is possible to enrich PRF-based fluid matrices with leukocytes, platelets and growth factors by means of a single alteration of the centrifugation settings within the clinical routine. Conclusions We postulate that the so-called low speed centrifugation concept (LSCC) selectively enriches leukocytes, platelets and growth factors within fluid PRF-based matrices. Further studies are needed to evaluate the effect of cell and growth factor enrichment on wound healing and tissue regeneration while comparing blood concentrates gained by high and low RCF. INTRODUCTION In recent years, several concepts have been introduced for clinically relevant tissue engineering by means of minimally invasive approaches. Currently, well-accepted models include pure biomaterial application [1–4] and the combination of biomaterials with autologous bone marrow aspirates [5, 6] or recombinant bone morphogenetic proteins (BMPs) [7, 8]. Although less invasive than autologous bone transplantation, the previously mentioned minimally invasive bone marrow aspirate methodologies are still reserved for only experienced surgeons, as these methods can also be associated with complications such as pain, infection, and damage to the adjacent organs during bone marrow retrieval. Furthermore, the optimal growth factor concentration needs to be determined for the use of BMPs. To resolve these issues, concentrates from the peripheral blood have been recently proposed as potential supporters in complex tissue engineering. In this context, several blood concentrate systems were introduced such as plasma-rich growth factors (PRGF) [9] and platelet-rich plasma (PRP) [10]. Both systems require the addition of non-autologous anticoagulants to generate fluid blood concentrates after centrifugation [9]. In addition to anticoagulants, multi-step centrifugation is needed to obtain PRP [11]. Moreover, PRGF and PRP focus on the advantages of platelets and their released growth factors to support tissue regeneration in different medical fields and aim to eliminate leukocytes from the final blood concentrates [12]. The introduction of platelet-rich-fibrin (PRF) in 2001 exemplified the first step toward the generation of blood-derived PRF matrices that do not require additional anticoagulation agents [13]. The centrifugation within a specific glass-based tube leads to the activation of the physiological coagulation cascade and, thus, the formation of a fibrin clot enriched with cells within the peripheral blood i.e., platelets and leukocytes. Recent developments in cellular and molecular biology and continuous research have increased the understanding of the wound healing and regeneration processes. Thus, the crucial role of leukocytes and their subgroups as main protagonists to modulate the various phases during wound healing became obvious [14]. In addition, platelets as well as the fibrin network are known to play a major role in the wound healing process [15]. Leukocytes participate in angiogenesis and lymphogenesis, whereas the fibrin network is a key player in the early stages of wound healing rendering its synergistic effects with platelets and its function as a reservoir of cytokines [16–18]. Nevertheless, to generate PRF the application of high relative centrifugal forces (RCF) (708 g) during the centrifugation process was described as essential. Furthermore, previous histological analyses of the PRF clot demonstrated that platelets and inflammatory cells within the fibrin scaffold accumulate mainly in the proximal portion of the PRF clot [19]. Therefore, we questioned to what extent adjusting the applied RCF could influence the cellular distribution within the solid PRF matrix, aiming to generate modified centrifugation protocols to enhance the regenerative capacity of PRF-based matrices. Thereby, fine tuning of the centrifugation process in terms of RCF reduction and slight increase of the centrifugation time resulted in an advanced PRF with enhanced leukocyte numbers, especially neutrophilic granulocytes. Moreover, the platelets and leukocytes within the advanced PRF were evenly distributed over the entire clot compared to PRF [19]. Based on these results, the question was raised to what extent a systematic reduction in RCF within fluid PRF matrices might have any influence on the increase of platelets and leukocytes as well as growth factors within the obtained blood concentrates. In this context, the present study demonstrates a systematic analysis of the RCF influence on fluid PRF-based matrices. Based on the first introduced PRF, we halved the revolutions per minutes (rpm), which according to the radius of the respective centrifuge (110 mm) led to a reduction of the RCF by four times in a stepwise approach to examine a wide RCF range (i.e., 710–44 g) including the high, medium and low RCF, systematically. Simultaneously, the centrifugation time was kept constant to exclude its impact. To the best of our knowledge, the present study is the first to analyze the RCF impact on human blood concentrates to determine the leukocyte and platelet numbers as well as the growth factor release potential within PRF-based matrices. The aim of the study was to determine to what extent a controlled reduction of the RCF, by modifying the centrifugation setting rpm, could influence the platelet and leukocyte total number as well as the growth factor release within fluid PRF-based matrices. MATERIALS AND METHODS Systematic protocols for PRF-based matrices To evaluate the high-, medium- and low-RCF spectrum, three different experimental centrifugation protocols for the systematic analysis series were established by decreasing the RCF within a wide range (710–44 g) with a constant centrifugation time. Based on PRF (708 g), a stepwise reduction of the rpm in half and, thus, a reduction of the RCF four times were performed for each protocol as follows: I:710 g; 2400 rpm; 8 minII:177 g; 1200 rpm; 8 minIII:44 g; 600 rpm; 8 min PRF preparation For this experiment, the blood of six healthy volunteers (three males and three females) was collected for each of the evaluated protocols. The tubes were immediately placed in the centrifuge and prepared according to the previously mentioned established protocols. A Duo centrifuge (Process for PRF, Nice, France) was used to perform the centrifugation procedure. This centrifuge has a fixed angle rotor with a radius of 110 mm. Written informed consent was obtained from

Read the complete text